Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 65 Neoplasm Metastasis 14 Brain Neoplasms 10 Neoplasms 9 Endometrial Neoplasms 8 Prostatic Neoplasms 7 Glioblastoma 7 Ovarian Neoplasms 6 Triple Negative Breast Neoplasms 5 Glioma 5 Sarcoma 4 Recurrence 3 Neoplasms by Site 3 Meningioma 3 Liposarcoma 3 Carcinoma, Non-Small-Cell Lung 3 Breast Diseases 3 Unilateral Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma, Ewing 2 Osteosarcoma 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Advanced Breast Cancer 2 Venous Thromboembolism 1 Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 4 Cyclophosphamide 4 exemestane 3 Taxes 3 Tamoxifen 3 Letrozole 3 Doxorubicin 3 Anastrozole 3 Trastuzumab 2 Leuprolide 2 Immunotherapy 2 Goserelin 2 Carboplatin 2 trastuzumab biosimilar HLX02 1 ribociclib 1 pegfilgrastim 1 elacestrant 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Vitamins 1 Standard of Care 1 Radiosurgery 1 Psychiatric Rehabilitation 1 Practice Guidelines as Topic 1 PF-05280014 1 Ontruzant 1 Omeprazole 1 Ogivri 1 Neoadjuvant Therapy 1 Methods 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms, Male × abemaciclib × 1 year × Clear all

NCT05501704 2026-04-30

ETHAN - ET for Male BC

Dana-Farber Cancer Institute

Phase 2 Recruiting

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡